Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil

Renal medullary carcinoma (RMC) is rare, accounting for less than 1% of all renal neoplasms. Case reports suggest RMC is highly aggressive, poorly responsive to chemotherapy, often metastatic at diagnosis, affects young men with sickle cell trait, and median overall survival (mOS) is less than 12 mo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Maroja Silvino, Marina Cavalcanti, Venchiarutti Moniz, Camila Motta, Munhoz Piotto, Gustavo Henrique, Siqueira, Sheila, Galapo Kann, Ariel, Dzik, Carlos
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications, Pavia, Italy 2013
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804819/
https://ncbi.nlm.nih.gov/pubmed/24179656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2013.e44
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares